EUCTR2015-003916-19-AT进行中（未招募）不适用
Perioperative Levetiracetam for seizure prophylaxis in brain tumor patients. Prospective evaluation of side effects and efficacy - LAHENE Study
Karl Landsteiner Institut für klinische Neurologie und Neuropsycholigie0 个研究点目标入组 100 人开始时间: 2015年11月25日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •adult patients (age 18-90) planned to undergo brain surgery because of supratentorial brain tumor
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 50
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 50
排除标准
- •Contraindication against Levetiracetam , preexisting anticonvulsive medication
研究者
相似试验
尚未招募
3 期
Prophylactic antiseizure medication in post cardiac arrest childreCTRI/2024/05/067855All India Institute of Medical Sciences Raipur
已完成
4 期
Assess Safety and Efficacy of Levetiracetam(LEV;Keppra)for Seizure PreventionTraumatic Brain InjurySubarachnoid HemorrhageNCT00618436University of Cincinnati52
尚未招募
不适用
Prevention of post stroke seizures in patients with cerebral venous sinus thrombosisCTRI/2021/03/031981DHRICMR
进行中（未招募）
3 期
A trial to prevent epilepsy in people having surgery for a meningioma brain tumourIntracranial meningioma and epilepsyNervous System DiseasesISRCTN14381346niversity of Liverpool1,004
撤回
2 期
Intravenous Levetiracetam as First-line Anticonvulsive Treatment in Patients With Non-convulsive Status EpilepticusStatus Epilepticus, Non-ConvulsiveNCT00603135University Hospital, Basel, Switzerland